Inhibrx Biosciences To Host A Live Webcast Presentation On Tuesday, April 21, 2026, To Provide A Clinical Update From Its Phase 1/2 Study Evaluating Ozekibart In Combination With FOLFIRI In Patients With Locally Advanced Or Metastatic, Unresectable Colorectal Cancer